In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Axogen Inc. (NASDAQ:AXGN) reported that Flynn James E has picked up 1,838,225 of common stock as of 2016-12-15.
The acquisition brings the aggregate amount owned by Flynn James E to a total of 1,838,225 representing a 5.59% stake in the company.
For those not familiar with the company, AxoGen is a human tissue company based in Alachua, Florida making products to remedy peripheral nerve damage. In 2013 the company raised $18 million in its Initial Public Offering. AxoGen uses a cell graft technology AVANCE to mimic a human nerve.
A glance at Axogen Inc. (NASDAQ:AXGN)’s key stats reveals a current market capitalization of $291.15 million based on 32.90 million shares outstanding and a price at last close of $8.75 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-10-07, Wendell picked up 13,333 at a purchase price of $7.50. This brings their total holding to 13,333 as of the date of the filing.
On the sell side, the most recent transaction saw Mandato unload 42,168 shares at a sale price of $8.30. This brings their total holding to 1,226,773. .
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Axogen Inc. (NASDAQ:AXGN) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
